Gabriele Berman

Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Cerebrospinal fluid shunting or dural venous sinus stenting to preserve vision in idiopathic intracranial hypertension (IIH Intervention): protocol for an open-label, multicentre, randomised controlled phase IIb trial.

Cerebrospinal fluid shunting or dural venous sinus stenting to preserve vision in idiopathic intracranial hypertension (IIH Intervention): protocol for an open-label, multicentre, randomised controlled phase IIb trial.

Journal: BMJ open

Published: August 03, 2026

Infographic: a randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients.

Infographic: a randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients.

Journal: Eye (London, England)

Published: July 04, 2026

Letter to the Editor. Enhancing comparability in idiopathic intracranial hypertension research through standardized outcome measures.

Letter to the Editor. Enhancing comparability in idiopathic intracranial hypertension research through standardized outcome measures.

Journal: Neurosurgical focus

Published: July 01, 2026

Infographic: efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity.

Infographic: efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity.

Journal: Eye (London, England)

Published: May 30, 2026

Adult Idiopathic Intracranial Hypertension Without Papilledema: Systematic Review of Literature and Future Perspectives.

Adult Idiopathic Intracranial Hypertension Without Papilledema: Systematic Review of Literature and Future Perspectives.

Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society

Published: May 14, 2026

Infographic: efficacy and safety of intravitreal siRNA therapy for acute NAION (QRK207 trial).

Infographic: efficacy and safety of intravitreal siRNA therapy for acute NAION (QRK207 trial).

Journal: Eye (London, England)

Published: May 13, 2026

Infographic: optic nerve decompression surgery for NAION (IONDT Trial).

Infographic: optic nerve decompression surgery for NAION (IONDT Trial).

Journal: Eye (London, England)

Published: May 10, 2026

Case Report: Vision-threatening manifestations of choroidal osteomas and papilloedema in presumed Camurati-Engelmann disease.

Case Report: Vision-threatening manifestations of choroidal osteomas and papilloedema in presumed Camurati-Engelmann disease.

Journal: Frontiers in neurology

Published: March 16, 2026

Infographic: teprotumumab for the treatment of active thyroid eye disease.

Infographic: teprotumumab for the treatment of active thyroid eye disease.

Journal: Eye (London, England)

Published: February 25, 2026

Progressive weakness but a lot of nerve: noninvasive OCT findings confirm ARSACS.

Progressive weakness but a lot of nerve: noninvasive OCT findings confirm ARSACS.

Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie

Published: February 17, 2026

Comment: Clinical and Imaging Characteristics of Uveitic Optic Disc Edema.

Comment: Clinical and Imaging Characteristics of Uveitic Optic Disc Edema.

Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society

Published: February 17, 2026

Infographic: Teprotumumab for thyroid-associated ophthalmopathy.

Infographic: Teprotumumab for thyroid-associated ophthalmopathy.

Journal: Eye (London, England)

Published: January 29, 2026

Showing 1-12 of 37

Last Updated: 09/26/2026